Among the ophthalmological variables assessed, IL-5, G-CSF, and CCL11/eotaxin-1 concentrations were identified as the most distinguishing variables to discriminate patients with CAD and comorbid T2DM from those without T2DM. This evidence concerns the gene CSF3 and type 2 diabetes mellitus.